From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
 | PSA (ng/mL) | ||
---|---|---|---|
 ≤ 10 | 10–20 |  > 20 | |
ISUP grade (n = 189) |  |  |  |
1 | 3 (38%) | 2 (25%) | 3 (38%) |
2 | 23 (56%) | 12 (29%) | 6 (15%) |
3 | 26 (52%) | 8 (16%) | 16 (32%) |
4 | 19 (56%) | 9 (26%) | 6 (18%) |
5 | 29 (52%) | 18 (32%) | 9 (16%) |
Unknowna | 1 (20%) | 1 (20%) | 3 (60%) |